Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) EV to EBIT (2015 - 2026)

Kamada's (KMDA) quarterly EV to EBIT came in at 37.15 in Q2 2026, down 30.82% on a YoY basis from 53.7 in Q2 2025, and down 36.69% quarter-over-quarter from 58.67 in Q1 2026.

Analysis

Kamada (KMDA) EV to EBIT (2015 - 2026) Analysis & Trends

Kamada (KMDA) has reported EV to EBIT for 12 consecutive years, with 37.15 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, EV to EBIT fell 30.82% year-over-year to 37.15; the trailing twelve-month figure through Jun 2026 stood at 12.69 (down 15.62% YoY), and the FY2025 full-year result was 9.77, up 1.34% from the prior year.
  • EV to EBIT fell to 37.15 in Q2 2026 per KMDA's latest filing, from 58.67 in the prior quarter.
  • Across five years, EV to EBIT topped out at 915.97 in Q1 2022 and bottomed at 88.06 in Q2 2022.
  • Historically, EV to EBIT has averaged 125.64 across 5 years, with a median of 49.2 in 2025.
  • The widest YoY moves for EV to EBIT: up 1192.86% in 2022, down 159.1% in 2022.
  • Over 5 years, EV to EBIT stood at 35.51 in 2022, then soared by 143.98% to 86.63 in 2023, then plunged by 56.05% to 38.07 in 2024, then soared by 89.59% to 72.18 in 2025, then plunged by 48.54% to 37.15 in 2026.
  • According to Business Quant data, EV to EBIT over the past three periods registered 37.15, 58.67, and 72.18 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.30 Bn 197.31 Bn 7.24 Bn
2 Gilead Sciences 180.97 Bn 177.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.27 Bn 124.42 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.93 Bn 74.93 Bn 3.93 Bn
5 Argenx Se 61.53 Bn 56.35 Bn 1.37 Bn
6 Moderna 54.27 Bn 49.13 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.46 Bn 31.15 Bn 992.69 Mn
8 Biogen 31.16 Bn 29.88 Bn 1.96 Bn
9 Roivant Sciences 30.08 Bn 30.08 Bn 1.16 Mn
10 Kamada 473.85 Mn 403.72 Mn 22.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.15
Mar 31, 2026 58.67
Dec 31, 2025 72.18
Sep 30, 2025 41.85
Jun 30, 2025 53.70
Mar 31, 2025 38.98
Dec 31, 2024 38.07
Sep 30, 2024 44.70
Jun 30, 2024 40.52
Mar 31, 2024 67.90
Dec 31, 2023 86.63
Sep 30, 2023 42.77
Jun 30, 2023 81.61
Mar 31, 2023 626.74
Dec 31, 2022 35.51
Sep 30, 2022 66.66
Jun 30, 2022 -88.06
Mar 31, 2022 915.97
Dec 31, 2021 -45.27
Sep 30, 2021 -170.77